Columbia Wanger Asset Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
TCM
O
CCA
RIM
Columbia Wanger Asset Management's RGEN Position: Q1 2017 in Review
Columbia Wanger Asset Management sold out of Repligen (RGEN) in Q1 2017, closing a stake of 294,991 shares — an estimated $9.09M sold.
Columbia Wanger Asset Management first reported a position in RGEN in Q1 2016 and held it in 4 quarters. The position peaked at $21.9M in Q2 2016. 180 funds tracked by Wall St. Rank hold RGEN as of Q1 2017.
- Columbia Wanger Asset Management reported no remaining Repligen position as of Q1 2017 after selling out during the quarter.
- Columbia Wanger Asset Management sold 294,991 Repligen shares in Q1 2017, an estimated $9.09M.
- Columbia Wanger Asset Management first reported a position in Repligen in Q1 2016 and held it in 4 quarters.
- Columbia Wanger Asset Management's Repligen position peaked at $21.9M in Q2 2016.
- 180 funds tracked by Wall St. Rank held Repligen as of Q1 2017.
Based on Columbia Wanger Asset Management's 13F filing for Q1 2017, filed 12 May 2017.